ProSomnus, Inc. announced plans to design a head-to-head clinical trial comparing its precision oral appliance therapy (OAT) and hypoglossal nerve stimulation (HGNS) in treating patients with severe OSA. The clinical trial plans follow updated results from the First Line Obstructive Sleep Apnea Treatment Study (FLOSAT), a prospective, independent, head-to-head, crossover […]
Tag: PROSOMNUS
ProSomnus Survey Finds 71% of Snorers Have Never Consulted a Healthcare Professional
ProSomnus, Inc. released the results of a survey conducted in partnership with Prodege, a cutting-edge consumer marketing and insights platform, on the major obstacles to identifying and treating snoring and OSA, including a lack of awareness of where to seek medical advice. Key findings of the survey of 1,000 people […]
ProSomnus Presents Further OAT OSA Validation Data at AADSM and ATS
ProSomnus, Inc. announced the presentation of four abstracts at the 2023 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, held May 19-21 in Philadelphia, Pennsylvania, and two abstracts at the American Thoracic Society (ATS) 2023 International Conference, held May 19-24 in Washington, D.C. The data presented at both meetings […]
ProSomnus OSA Medical Devices Receives Patent Allowance Covering Manufacturing Process
ProSomnus, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) has allowed a patent application covering the Company’s proprietary automated manufacturing process for the Company’s precision medical devices; this is the third patent to issue in this family, including already-issued USPN 10,213,280 and USPN 9,808,327. ProSomnus’s intellectual property […]
ProSomnus to Present New OAT Data at SLEEP 2022
ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus will share data in three poster presentations at SLEEP 2022, the Annual Meeting of […]
ProSomnus Presents Data Validating Proprietary Oral Appliances at AADSM 2022
ProSomnus has announced the results of three studies evaluating its oral appliance therapy devices in the treatment of obstructive sleep apnea. ProSomnus presented the data in three poster presentations at the 2022 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, held from May 13-15 in Dallas, Texas. Emerging data […]
U.S. Army Dental Civilian Corps is Advancing Standards in Dental Sleep Medicine
The U.S. Army Civilian Dental Corps and the U.S. Army Medical Command (MEDCOM), Dental Directorate are highlighting their joint advancements in dental sleep medicine, a field of dental practice that focuses on the use of oral appliance therapy to treat sleep-disordered breathing, including snoring and obstructive sleep apnea, as defined […]









